TRCT
NBTX

Tower Research Capital (TRC)’s Nanobiotix NBTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$31 – 5510
2026
Q1 		$31 Buy
+1
New +$26 ﹤0.01% 5049
2025
Q1 		– Sell
-7,921
Closed -$22.7K – 5586
2024
Q4 		$22.7K Buy
+7,921
New +$31.7K ﹤0.01% 3089
2024
Q2 		– Sell
-450
Closed -$2.92K – 5898
2024
Q1 		$2.92K Buy
+450
New +$3.18K ﹤0.01% 4963

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC)'s NBTX Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Nanobiotix (NBTX) in Q2 2026, closing a stake of 1 share — an estimated $31 sold.

Tower Research Capital (TRC) first reported a position in NBTX in Q1 2024 and held it in 3 quarters. The position peaked at $22.7K in Q4 2024. 19 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Nanobiotix position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1 Nanobiotix share in Q2 2026, an estimated $31.
  • Tower Research Capital (TRC) first reported a position in Nanobiotix in Q1 2024 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Nanobiotix position peaked at $22.7K in Q4 2024.
  • 19 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.